SGA
ONC

Strategic Global Advisors’s BeOne Medicines Ltd ONC Stock Holding History

Strategic Global Advisors’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$889K Buy
2,783
+1,386
+99% +$408K 0.13% 113
2026
Q1 		$415K Buy
1,397
+291
+26% +$94.2K 0.07% 133
2025
Q4 		$336K Buy
+1,106
New +$362K 0.05% 135

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Strategic Global Advisors's ONC Position: Q2 2026 in Review

Strategic Global Advisors increased its BeOne Medicines Ltd (ONC) stake by 99% in Q2 2026, buying an estimated $408K and bringing the position to 2,783 shares worth $889K. The position accounts for 0.13% of the portfolio, ranked #113.

Strategic Global Advisors first reported a position in ONC in Q4 2025 and has held it in 3 quarters since. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Strategic Global Advisors held 2,783 shares of BeOne Medicines Ltd worth $889K as of Q2 2026.
  • Strategic Global Advisors bought 1,386 BeOne Medicines Ltd shares in Q2 2026, an estimated $408K.
  • BeOne Medicines Ltd made up 0.13% of Strategic Global Advisors's portfolio in Q2 2026, its #113 holding.
  • Strategic Global Advisors first reported a position in BeOne Medicines Ltd in Q4 2025 and has held it in 3 quarters since.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Strategic Global Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.